Arnuity Ellipta

Asthma, Chronic Obstructive Pulmonary Disease, Seasonal Allergies + 1 more
Treatment
2 FDA approvals
20 Active Studies for Arnuity Ellipta

What is Arnuity Ellipta

Fluticasone furoateThe Generic name of this drug
Treatment SummaryFluticasone furoate is a steroid-based medicine used to treat inflammation. It comes in an inhaler and a nasal spray form and was approved by the FDA in 2007.
Veramystis the brand name
image of different drug pills on a surface
Arnuity Ellipta Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Veramyst
Fluticasone furoate
2007
22

Approved as Treatment by the FDA

Fluticasone furoate, otherwise known as Veramyst, is approved by the FDA for 2 uses which include Chronic Obstructive Pulmonary Disease and Asthma .
Chronic Obstructive Pulmonary Disease
Used to treat Chronic Obstructive Pulmonary Disease (COPD) in combination with Umeclidinium
Asthma
Used to treat Asthma in combination with Umeclidinium

Effectiveness

How Arnuity Ellipta Affects PatientsFluticasone furoate works in the body by activating certain receptors, blocking a protein that leads to inflammation, and decreasing inflammation in the lungs of rats.
How Arnuity Ellipta works in the bodyFluticasone furoate helps reduce inflammation in the body, although the exact way it works is unknown. Lab tests have shown it activates certain receptors and prevents some molecules from entering cells and causing inflammation.

When to interrupt dosage

The preferred measure of Arnuity Ellipta is contingent upon the determined affliction, including Sinusitis, Sinusitis and Perennial Allergic Rhinitis (PAR). The measure of dosage wavers, depending on the method of delivery (e.g. Respiratory (inhalation) or Powder - Respiratory (inhalation)) referenced in the table underneath.
Condition
Dosage
Administration
Chronic Obstructive Pulmonary Disease
, 0.0275 mg, 0.1 mg, 0.2 mg, 0.0275 mg/spray, 0.05 mg, 0.092 mg, 0.184 mg, 0.1 mg/pump actuation, 0.2 mg/pump actuation, 0.0275 mg/pump actuation
, Nasal, Spray, metered - Nasal, Spray, metered, Respiratory (inhalation), Powder - Respiratory (inhalation), Powder, Intrasinal, Spray, suspension, Spray, suspension - Intrasinal, Powder, metered - Respiratory (inhalation), Powder, metered
Asthma
, 0.0275 mg, 0.1 mg, 0.2 mg, 0.0275 mg/spray, 0.05 mg, 0.092 mg, 0.184 mg, 0.1 mg/pump actuation, 0.2 mg/pump actuation, 0.0275 mg/pump actuation
, Nasal, Spray, metered - Nasal, Spray, metered, Respiratory (inhalation), Powder - Respiratory (inhalation), Powder, Intrasinal, Spray, suspension, Spray, suspension - Intrasinal, Powder, metered - Respiratory (inhalation), Powder, metered
Seasonal Allergies
, 0.0275 mg, 0.1 mg, 0.2 mg, 0.0275 mg/spray, 0.05 mg, 0.092 mg, 0.184 mg, 0.1 mg/pump actuation, 0.2 mg/pump actuation, 0.0275 mg/pump actuation
, Nasal, Spray, metered - Nasal, Spray, metered, Respiratory (inhalation), Powder - Respiratory (inhalation), Powder, Intrasinal, Spray, suspension, Spray, suspension - Intrasinal, Powder, metered - Respiratory (inhalation), Powder, metered
Perennial Allergy
, 0.0275 mg, 0.1 mg, 0.2 mg, 0.0275 mg/spray, 0.05 mg, 0.092 mg, 0.184 mg, 0.1 mg/pump actuation, 0.2 mg/pump actuation, 0.0275 mg/pump actuation
, Nasal, Spray, metered - Nasal, Spray, metered, Respiratory (inhalation), Powder - Respiratory (inhalation), Powder, Intrasinal, Spray, suspension, Spray, suspension - Intrasinal, Powder, metered - Respiratory (inhalation), Powder, metered

Warnings

Arnuity Ellipta has seven contraindications and should not be utilized when facing any of the conditions listed in the subsequent table.Arnuity Ellipta Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Fluticasone Furoate may interact with Pulse Frequency
Asthma Acute
Do Not Combine
primary treatment of status asthmaticus
Do Not Combine
Status Asthmaticus
Do Not Combine
Pulse Frequency
Do Not Combine
Asthma
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Fluticasone Furoate may interact with Pulse Frequency
There are 20 known major drug interactions with Arnuity Ellipta.
Common Arnuity Ellipta Drug Interactions
Drug Name
Risk Level
Description
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Fluticasone furoate.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Fluticasone furoate.
Acteoside
Major
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Acteoside.
Aldesleukin
Major
The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone furoate.
Arnuity Ellipta Toxicity & Overdose RiskFluticasone furoate, when taken nasally, may be linked to adrenal suppression or an increased heart rate, although this has not been firmly established. It does not need to be adjusted for those with kidney issues, but should be used with caution in those with liver problems. It is not known to cause cancer, genetic damage, or reduced fertility. There have not been enough studies to determine its effects during pregnancy or breastfeeding, though animal studies have found birth defects and low adrenal hormone levels in offspring of mothers who took fluticasone. Children should be given the lowest dose possible and monitored for reduced growth. Elder
image of a doctor in a lab doing drug, clinical research

Arnuity Ellipta Novel Uses: Which Conditions Have a Clinical Trial Featuring Arnuity Ellipta?

252 active trials are underway to investigate the potential of Arnuity Ellipta to alleviate Sinusitis, Chronic Obstructive Pulmonary Disease (COPD) and Asthma.
Condition
Clinical Trials
Trial Phases
Chronic Obstructive Pulmonary Disease
101 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4
Seasonal Allergies
0 Actively Recruiting
Perennial Allergy
0 Actively Recruiting
Asthma
160 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4, Early Phase 1, Phase 3

Arnuity Ellipta Reviews: What are patients saying about Arnuity Ellipta?

5Patient Review
10/23/2016
Arnuity Ellipta for Severe Chronic Obstructed Lung Disease
Before taking this medication, I couldn't even walk up a flight of stairs without being out of breath. Now, I can do it with ease!
5Patient Review
3/21/2021
Arnuity Ellipta for Asthma
I found that the key to this medication's success is taking it in the morning. I was seeing sub-par results when taking it at night, but since switching to a morning dose I haven't needed my rescue inhaler in months!
5Patient Review
10/3/2016
Arnuity Ellipta for Severe Chronic Obstructed Lung Disease
4.3Patient Review
10/9/2016
Arnuity Ellipta for Asthma Prevention
This medication helped to fix my hoarse voice.
4Patient Review
10/31/2017
Arnuity Ellipta for Asthma Prevention
After only 12 days of using the arnuity inhaler, my son started to become extremely agitated. He said it felt like he was closed in, so we stopped giving it to him and will follow up with his pediatrician.
3Patient Review
5/17/2017
Arnuity Ellipta for Asthma
I'm much more compliant with my medication now that I only have to use it once a day. My breathing tests have improved, even though I am still short of breath.
2.7Patient Review
1/30/2020
Arnuity Ellipta for Asthma
This medication worked well at first, but I've recently experienced a lot of the listed side effects. My asthma has gotten worse, and I now have a runny nose, hoarse voice, and tight chest, among other things. I'm going to speak to my doctor about it and see if there's anything that can be done.
2Patient Review
1/11/2020
Arnuity Ellipta for Asthma
I'm not entirely sure what this medication is supposed to do, but it hasn't gotten rid of my dry cough. On the bright side, it has improved my whistling and wheezing.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about arnuity ellipta

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Arnuity Ellipta inhaler a steroid?

"This is a prescription inhaled corticosteroid that is taken once a day, in order to control and prevent asthma in adults and children who are at least five years old."

Answered by AI

How long does it take for Arnuity Ellipta to work?

"You may not see the full benefits of this drug for up to 2 weeks, or longer. If your symptoms don't improve, or they get worse, let your doctor know."

Answered by AI

Is Arnuity Ellipta good?

"Arnuity Ellipa is a preventative medicine meant to stop asthma symptoms before they start. It is not however a rescue inhaler and cannot be used to treat an asthma attack that is already happing."

Answered by AI

What is the generic for Arnuity Ellipta?

"Arnuity Ellipta is a corticosteroid used to treat the symptoms of asthma. It is not as popular as other corticosteroids and there are no generic alternatives."

Answered by AI

Clinical Trials for Arnuity Ellipta

Have you considered Arnuity Ellipta clinical trials? We made a collection of clinical trials featuring Arnuity Ellipta, we think they might fit your search criteria.
Have you considered Arnuity Ellipta clinical trials? We made a collection of clinical trials featuring Arnuity Ellipta, we think they might fit your search criteria.
Have you considered Arnuity Ellipta clinical trials? We made a collection of clinical trials featuring Arnuity Ellipta, we think they might fit your search criteria.